YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Kabra Drugs
Kabra Drugs
BSE: 524322NSE: ISIN: INE323K01017

7th-Sep-2020 17:08Source: BSE

Kabra Drugs - Board Meeting Intimation for Notice Of Board Meeting To Be Held On Tuesday, September 15Th, 2020

KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/09/2020 ,inter alia, to consider and approve Pursuant to Regulation 29(1) (a) & (2) of the SEBI (LODR) Regulations, 2015, notice is hereby given that a Meeting of the Board of Directors of the Company will be held on Tuesday, September 15th , 2020 at 12.30 P.M. to consider and approve, inter-alia, the Un-Audited Financial Results of the Company for the quarter ended on June 30, 2020
Further, the Trading Window for dealing in shares of the Company is already closed and shall open 48 hours after conclusion of the Board Meeting.